Provencio Norma Ann
Insider CIK 1343811 · VRX Director · BZH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BZH BEAZER HOMES USA INC | D To issuer | 2026-10-20 | 2026-10-20 | 7,199 | — | — | 0 | SEC↗ |
| BZH BEAZER HOMES USA INC | D To issuer | 2026-10-20 | 2026-10-20 | 10,600 | — | — | 0 | SEC↗ |
| BZH BEAZER HOMES USA INC | D To issuer | 2026-10-20 | 2026-10-20 | 98,189 | — | — | 7,199 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2025-11-17 | 2025-11-18 | 7,199 | — | $0 | 105,388 | SEC↗ |
| BZH BEAZER HOMES USA INC | P Buy | 2025-02-10 | 2025-02-10 | 5,000 | $21.93 | $109.7K | 10,600 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2024-11-15 | 2024-11-19 | 5,051 | — | $0 | 98,189 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2023-11-20 | 2023-11-21 | 6,024 | — | $0 | 93,138 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2022-11-14 | 2022-11-16 | 14,181 | — | $0 | 87,114 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2021-11-12 | 2021-11-16 | 7,679 | — | $0 | 72,933 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2020-11-16 | 2020-11-18 | 9,177 | — | $0 | 70,854 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2019-11-15 | 2019-11-19 | 8,002 | — | $0 | 61,677 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2018-11-15 | 2018-11-19 | 10,183 | — | $0 | 53,675 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2017-11-16 | 2017-11-17 | 4,887 | — | $0 | 43,492 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2016-11-17 | 2016-11-17 | 7,993 | — | $0 | 33,005 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2016-11-17 | 2016-11-21 | 7,993 | — | $0 | 33,005 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-05-02 | 2016-05-04 | 1,188 | — | $0 | 144,899 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-12-31 | 2016-01-04 | 344 | — | $0 | 143,711 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2015-11-12 | 2015-11-16 | 7,128 | — | $0 | 25,012 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-09-30 | 2015-10-02 | 196 | — | $0 | 143,367 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-06-30 | 2015-07-02 | 157 | — | $0 | 143,171 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-05-22 | 2015-05-27 | 1,607 | — | $0 | 143,014 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-03-31 | 2015-04-02 | 188 | — | $0 | 141,407 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-12-31 | 2015-01-05 | 266 | — | $0 | 141,219 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2014-11-14 | 2014-11-18 | 5,244 | — | $0 | 17,884 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-09-30 | 2014-10-02 | 290 | — | $0 | 140,953 | SEC↗ |
| BZH BEAZER HOMES USA INC | P Buy | 2014-08-01 | 2014-08-04 | 3,000 | $16.26 | $48.8K | 5,600 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-06-30 | 2014-07-01 | 302 | — | $0 | 140,663 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-05-23 | 2014-05-28 | 2,866 | — | $0 | 140,361 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-04-01 | 2014-04-02 | 5,000 | $132.18 | $660.9K | 137,495 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-03-31 | 2014-04-02 | 289 | — | $0 | 142,495 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-03-03 | 2014-03-05 | 5,000 | $141.62 | $708.1K | 142,206 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-02-03 | 2014-02-04 | 5,000 | $136.23 | $681.1K | 147,206 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-01-13 | 2014-01-14 | 5,000 | $133.00 | $665.0K | 152,206 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-12-31 | 2014-01-02 | 324 | — | $0 | 157,206 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2013-11-27 | 2013-12-02 | 1,765 | — | $0 | 156,882 | SEC↗ |
| BZH BEAZER HOMES USA INC | A Award | 2013-11-08 | 2013-11-12 | 3,280 | — | $0 | 12,640 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2013-11-01 | 2013-11-05 | 5,000 | $106.70 | $533.5K | 158,647 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-09-30 | 2013-10-02 | 365 | — | $0 | 163,647 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2013-09-06 | 2013-09-11 | 4,000 | $100.25 | $401.0K | 163,282 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2013-09-03 | 2013-09-04 | 5,000 | $99.68 | $498.4K | 167,282 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-06-30 | 2013-07-02 | 422 | — | $0 | 172,282 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2013-06-11 | 2013-06-13 | 6,000 | $85.26 | $511.6K | 171,860 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-06-04 | 2013-06-06 | 1,362 | $88.21 | $120.1K | 177,860 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer deriv | 2013-05-30 | 2013-06-03 | 1,320 | — | $0 | 1,197 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-05-30 | 2013-06-03 | 5,798 | $90.81 | $526.5K | 179,222 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-05-30 | 2013-06-03 | 1,320 | — | $0 | 185,020 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-05-24 | 2013-05-28 | 5,022 | — | $0 | 183,700 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-03-31 | 2013-04-02 | 466 | — | $0 | 178,678 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-12-31 | 2013-01-03 | 585 | — | $0 | 173,987 | SEC↗ |
| BZH BEAZER HOMES USA INC | P Buy | 2012-11-14 | 2012-11-16 | 3,280 | — | $0 | 9,360 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-09-30 | 2012-10-02 | 633 | — | $0 | 172,769 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-30 | 2012-07-03 | 777 | — | $0 | 172,769 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-04 | 2012-06-04 | 8,062 | — | $0 | 171,992 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-05-22 | 2012-05-24 | 500 | $47.75 | $23.9K | 164,430 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-05-22 | 2012-05-24 | 725 | $47.75 | $34.6K | 168,155 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-05-22 | 2012-05-24 | 3,000 | $47.74 | $143.2K | 167,430 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-03-31 | 2012-04-03 | 558 | — | $0 | 163,930 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2011-12-31 | 2012-01-04 | 602 | — | $0 | 163,372 | SEC↗ |